MedPath

M.D. ANDERSON CANCER CENTER

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia

Phase 2
Completed
Conditions
Leukemia
Fungal Infection
Interventions
First Posted Date
2009-07-09
Last Posted Date
2019-02-27
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
25
Registration Number
NCT00936117
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer

Phase 2
Completed
Conditions
Advanced Cancers
Interventions
Device: Vapotherm
Device: BIPAP
First Posted Date
2009-07-08
Last Posted Date
2016-03-02
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
30
Registration Number
NCT00934128
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

The Impact of Obesity and Obesity Treatments on Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2009-07-07
Last Posted Date
2016-02-19
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
25
Registration Number
NCT00933309
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Lenalidomide and Paclitaxel in Prostate Cancer

Phase 1
Terminated
Conditions
Prostate Cancer
Interventions
First Posted Date
2009-07-07
Last Posted Date
2016-10-26
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
17
Registration Number
NCT00933426
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Phase 2
Active, not recruiting
Conditions
Breast Cancer
Interventions
Drug: Standard Therapy
Procedure: Local Therapy
First Posted Date
2009-06-26
Last Posted Date
2025-05-31
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
35
Registration Number
NCT00929214
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

Not Applicable
Withdrawn
Conditions
Head and Neck Cancer
Oropharyngeal Cancer
Gastroesophageal Reflux Disease
Interventions
First Posted Date
2009-06-25
Last Posted Date
2012-09-07
Lead Sponsor
M.D. Anderson Cancer Center
Registration Number
NCT00928161

Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy

Terminated
Conditions
Breast Cancer
Interventions
Procedure: Breast MRI
Procedure: Mammogram
First Posted Date
2009-06-22
Last Posted Date
2011-11-08
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
10
Registration Number
NCT00925405
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans

Conditions
Venous Thromboembolism
Cancer
Interventions
Behavioral: Questionnaires
First Posted Date
2009-06-22
Last Posted Date
2019-08-30
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
1187
Registration Number
NCT00925808
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

A Pilot Study of Bevacizumab for Neoplastic Meningitis

Phase 1
Completed
Conditions
Neoplastic Meningitis
Interventions
First Posted Date
2009-06-19
Last Posted Date
2020-12-31
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
20
Registration Number
NCT00924820
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Obatoclax for Systemic Mastocytosis

Phase 2
Terminated
Conditions
Leukemia
Systemic Mastocytosis
Interventions
First Posted Date
2009-06-11
Last Posted Date
2011-11-04
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
3
Registration Number
NCT00918931
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath